Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa
NCT04925687
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL:
Intravitreal autologous CD34+ cells
Sponsor
University of California, Davis
Collaborators
[object Object]
[object Object]